Originator Company: Istituto Scientifico H San Raffaele Active Companies: Istituto Scientifico H San Raffaele; MegaPharm Ltd; MolMed SpA; TTY Biopharm Co Ltd
conditional marketing authorization (CMA) was granted as a patient-specific adjunctive treatment in haplo-identical haematopoietic stem-cell transplantation (HSCT) for adults with high-risk hematological malignancies [ 1794144 ]. By November 2018...suspended the program due to other higher priority projects and a change in Japanese policy on HLA mismatched hematopoietic stem cell transplantation. Takara would wait for the EMA's review of the MAA to develop a more effective project plan [ 1586171
Immune
Registered
Thymidine kinase modulator
Blood system agent; Immunosuppressant
Graft versus host disease